LONDON, United Kingdom, 22nd February, 2024 — Sixfold Bioscience, a leading AI-enabled RNA delivery company, today announced that Dr Søren Ottosen, VP of Research, will present at the ‘RNA Leaders Europe’ conference on March 13-14, 2024 | Basel, Switzerland.
RNA Leaders Europe is a leading conference focused on RNA delivery and therapeutics, bringing together leading companies in the space to discuss recent developments, as well as explore partnering and investment opportunities.
Sixfold Bioscience VP of Research, Dr Søren Ottosen, will be presenting his talk on “‘Mergo®: a scalable and programmable conjugation-based delivery system for short oligonucleotides” in the 'Delivery Showcase' session at Wednesday, 13 March 2024 12:35–12:50 CET (Central European Time, GMT+01:00).
Sixfold Biosciences is a biotechnology company solving one of the most critical challenges preventing the greater utilization of powerful RNA medicines: delivery. Sixfold’s solution takes evolution as inspiration, learning and mimicking how RNA is naturally delivered to different cell types in the body. Using advanced AI and Bayesian Optimization, Sixfold is learning the language that encodes RNA-shuttle interactions and destination selection, unlocking new cell types for treatment.
Sixfold to present at the 5th Nordic Nucleic Acid Based Medicine Industry Network Meeting
September 12, 2024
Read moreSixfold Bioscience Present Research on Generative Modeling Platform at ICML 2024
July 26, 2024
Read moreGenerative Machine Learning enabled RNA delivery receives UKRI funding.
July 23, 2024
Read more